Meet our

Clinical advisory board

Dr. Ethan Basch
  • Member, UNC Lineberger Comprehensive Cancer Center Director
  • Professor in UNC-Chapel Hill Department of Medicine, Hematology and Oncology
Show more Show less
Dr Fabrice Denis MD, PhD
  • Past President of the National union of Radiation Therapists Oncologists
  • Associate researcher at CORIA CNRS UMR 6614
  • Expert Telemedicine, Jean Bernard Inter-Regional Cancer Institute
Show more Show less
Dr. Alain Livartowski
  • Department of Oncology, Institut Curie
  • Lead, eSanté projects
Show more Show less
Dr. Jean-Jacques Zambrowski
  • Consultant,Health policy and economics
  • Educational Director, Paris Descartes University
Show more Show less

Clinical studies

Moovcare® has undergone six years of rigorous development and clinical validation, culminating in CE certification as a Class I medical device.


Final results from phase III multicentric prospective randomized trial, presented at ASCO 2018, show an improvement in overall survival of 7.6 months and QOL To read about the trial results, published in JAMA, January 2019.


Moovcare® study timeline